Clinical Trial Update: Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Anti-CCR9 CAR T Cells for T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Anti-CCR9 CAR T Cells

Snippet

Sponsor: University College, London | Conditions: T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma | Phase 1 | Status: RECRUITING